Related Experiment Video
Updated: Sep 10, 2025

Symptom Assessment of Patients with Allergic Rhinitis Using an Allergen Exposure Chamber
Published on: March 3, 2023
Asthma and Allergy Comorbidity Among the US Population Aged 2 Years or Older, National Health Interview Survey, 2021
Cynthia A Pate1, Lara J Akinbami2, Carol Johnson1
1Division of Environmental Health Science and Practice, National Center for Environmental Health, Centers for Disease Control and Prevention, Atlanta, GA, USA.
Objectives:
Asthma has substantial morbidity and impact on quality of life. Symptoms can worsen when asthma coexists with allergy. We assessed the prevalence of asthma-allergy comorbidity in a nationally representative sample.
Methods:
We used 2021 National Health Interview Survey data for 7343 children and adolescents aged 2 to 17 years and 29 329 adults aged ≥18 years to estimate the prevalence of asthma, allergy symptoms, and lifetime allergy diagnosis. We assessed associations between asthma-allergy comorbidity and characteristics (sex, age group, race and ethnicity, family income, region, urbanicity) and between asthma attacks and allergy by using logistic regression.
Results:
Almost 8% of people aged ≥2 years had asthma, and 52.3% had allergy symptoms. Among children and adolescents, boys had a higher prevalence of asthma-allergy comorbidity than girls (6.2%; 95% CI, 5.3%-7.2% vs 5.0%; 95% CI, 4.2%-5.9%). Among adults, men had a lower prevalence of asthma-allergy comorbidity than women (4.9%; 95% CI, 4.5%-5.4% vs 8.3%; 95% CI, 7.7%-8.8%). The prevalence of asthma-allergy comorbidity was higher among people with low income (<100% vs ≥200% federal poverty level) and non-Hispanic Black (vs non-Hispanic White) people. Among people with asthma, 82.1% had allergy symptoms and 67.3% had a lifetime allergy diagnosis. The prevalence of allergy symptoms differed by sex among adults with asthma but not among children and adolescents with asthma. Among adults with asthma, asthma attacks were associated with allergy symptoms (adjusted prevalence ratio = 1.23; 95% CI, 1.04-1.46).
Conclusion:
Disparities in asthma-allergy comorbidity exist by sex, family income, and race and ethnicity. These findings support national asthma management guidelines on the importance of identifying and treating comorbid allergies among people with asthma.
More Related Videos
06:34A Component-resolved Diagnostic Approach for a Study on Grass Pollen Allergens in Chinese Southerners with Allergic Rhinitis and/or Asthma
Published on: June 4, 2017
03:40Acupoint Catgut Embedding Therapy in Traditional Chinese Medicine for Managing Allergic Rhinitis
Published on: December 20, 2024
Related Concept Videos
Asthma-IV: Diagnostic and Management
Clinical Assessment for Asthma:
This is the first step in diagnosing and managing asthma. It includes:
Asthma-II: Pathophysiology and Classification
Additionally, environmental and genetic factors play crucial roles in determining an individual's susceptibility to asthma and the severity of their condition.
Critical processes in asthma pathophysiology include:
Asthma-III: Symptoms and Complications
Classification of Asthma
Asthma-I: Introduction
Asthma: Pathogenesis and Management
Asthma is classified as allergic and non-allergic. Allergens such as dust mites, pollen, and pet dander trigger allergic asthma, while factors like cold air, intense emotions, or exercise can induce non-allergic asthma.
Antiasthma Drugs: Mast Cell Stabilizers and Anti-IgE Drugs
Mast cell stabilizers, such as cromolyn (also known as sodium cromoglycate) and nedocromil (Tilade), are effective drugs in asthma management. These stabilizers hinder histamine release by skillfully obstructing the activation of mast cells and other cellular entities. Notably, they navigate this task without...